Guidelines on the Management of Type 2 Diabetes

The Emirates Diabetes Society (EDS) consensus guidelines for the management of type 2 diabetes were published in 2020.1 To produce the consensus guideline, the EDS convened a panel of experts who were tasked with adapting key research findings and international guidelines for local use. The final publication was reviewed by the panel and represented its collective analysis and recommendations. It was particularly based on the 2019 guideline on diabetes, prediabetes, and cardiovascular disease produced by the European Association for the Study of Cardiology (ESC) in collaboration with the European Association for the Study of Diabetes (EASD),2 and on the 2020 Standards of Care from the American Diabetes Association (ADA).3 The process was facilitated by an unrestricted grant from Novo Nordisk who did not participate in any of the meetings or the drafting of the manuscript. Key recommendations were made on screening, interventions for prediabetes, structured education, physical activity, nutrition therapy, and pharmacotherapy. The recommendations on pharmacotherapy took account of the person’s risk of cardiovascular disease. How do the EDS consensus guidelines compare with other guidelines and consensus statements on the management of type 2 diabetes, and what approaches could be taken when the EDS consensus guidelines are reviewed? What Are Guidelines and Consensus Statements?